CClinicalTrials.gg
CompletedNCT03044522Updated Dec 11, 2017

Use of a Nurse Pain Educator for Patients With Chronic Pain

An interventional study of Opioid Education in Chronic Pain, Opioid Use and Nurse's Role, sponsored by NEMA Research, Inc.. Completed at 4 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-12-11.

Sponsored by NEMA Research, Inc. · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
183
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This multicenter randomized (block randomization) controlled parallel arm pilot study comparing the incorporation vs no incorporation of a Nurse Pain Educator into clinics that treat chronic non cancer pain patients with opioid analgesics. Subjects who are either opioid naïve or opioid experienced will be enrolled into the study.

Read the detailed description

The Nurse Pain Educator arm shall have two phases: a Pre-Teaching Phase and a Teaching/Knowledge Maintenance Phase. During the Pre-Teaching Phase, all subjects who are enrolled will complete different baseline assessments and will be prescribed an opioid. Subjects will then enter the Teaching/Knowledge Maintenance Phase. Subject enrolled into the Nurse Pain Educator arm will be educated on different opioid pain management topics with a focus on safe and appropriate use and consumption of opioid analgesics. Subjects will meet monthly with the Nurse Educator for up to 5 months for reinforcement of their training and to assess their use of their medication, their quality of life and their physical and mental well-being.

Subjects who are enrolled into the study arm with no Nurse Pain Educator will be monitored every month to assess their use of their medication, their quality of life and their physical and mental well-being. No intervention will be conducted with these subjects beyond that of standard of care at the facility. Subjects will be evaluated monthly but primary differences in outcomes will compare baseline to 6 months.

02

Conditions studied

  • Chronic Pain
  • Opioid Use
  • Nurse's Role

Browse trials for

03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

This study's enrollment of 183 is above the median of 60 across 2,161 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

NEMA Research, Inc. is the lead sponsor of 15 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Ability to read, understand, and provide written informed consent
  • Male or Female patients ≥ 18 years of age
  • Diagnosed with non-cancer pain for >3 months
  • Ability to meet study requirements (i.e., can attend monthly visits, able to complete questionnaires, etc.)
  • Prescribed an oral opioid that will last duration of the study period
  • Provide a completed Opioid Patient Prescriber Agreement

Exclusion criteria

Exclusion Criteria:

  • Diagnosed with chronic cancer pain
  • Personal or family history of alcohol or drug abuse in the past 5 years
  • Personal or family history of major mental illness
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
183 participants (actual)

Study arms

  • No intervention
    No Nurse Education

    Subjects who are enrolled into study arm with no Nurse Pain Educator will be monitored every month to assess their use of their medication, quality of life, physical and mental well-being. No intervention will be conducted with these subjects beyond that of standard of care at the facility.

  • Other
    Nurse Education

    Subject enrolled into the Nurse Pain Educator arm will be educated (Opioid Education) on different opioid pain management topics with a focus on safe and appropriate use and consumption of opioid analgesics.

    Other: Opioid Education

Interventions

  • OtherOpioid Education
06

What researchers measure

Primary outcomes

  1. Change in Opioid Consumption

    Difference between opioid consumption in subjects with and without education by a Nurse Pain Educator as measured by Total Morphine Sulfate Equivalent of Prescription from change in baseline to end of study and at each month.

    Time frame: 6 Months

  2. Change Opioid Consumption

    Difference between opioid consumption in subjects with and without education by a Nurse Pain Educator as measured by a Qualitative Assessment of Opioid consumption from change in baseline to end of study and at each month.

    Time frame: 6 Months

Secondary outcomes

  1. Change in Current Opioid Misuse Measure (COMM)

    Assess Safe and Appropriate Use of Opioids by measuring change in Currenet Opioid Misuse Measure from baseline to end of study and at each month.

    Time frame: 6 Months

  2. Change in Pain Medicine Questionnaire (PMQ)

    Assess Safe and Appropriate Use of Opioids by measuring change in Pain Medicine Questionnaire from baseline to end of study and at each month.

    Time frame: 6 Months

  3. Change in SF-36

    Assess Quality of Life and Daily Function by measuring the change in the SF-36 Health Outcomes survey from baseline to end of study and at each month.

    Time frame: 6 Months

  4. Change in Quality of Life Scale

    Assess Quality of Life and Daily Function by measuring the change in the 11 point Quality of Life Scale from baseline to end of study and at each month.

    Time frame: 6 Months

Other outcomes

  1. Online Pain Assessment Tool

    Assess ease of use and outcomes of the Online Pain Assessment Tool from change in baseline to end of study in the Online Pain Assessment Tool scores

    Time frame: 6 Months

07

Study locations

4 sites
  • Headache and Pain Management Center of SWFL
    Fort Myers, Florida 33912, United States
  • Gold Coast Research
    Plantation, Florida 33317, United States
  • Mid America Physiatrists
    Overland Park, Kansas 66210, United States
  • Piedmont Family Practice
    Warrenton, Virginia 20186, United States
08

References and documents

Individual participant data

Plan to share: No — The data will be presented in a manuscript/publication in a peer-reviewed journal.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03044522
Lead sponsor
NEMA Research, Inc.
Collaborators
Food and Drug Administration (FDA)
Responsible party
Sponsor
First posted
Feb 7, 2017
Start date
Nov 14, 2016
Primary completion
Sep 21, 2017
Completion
Nov 21, 2017
Last update
Dec 11, 2017

Study contacts

Joseph Pergolizzi, MD
principal investigator · NEMA Research, Inc.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion